BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of entries related to MKN45 cell line is 244
| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PROM1 | 9454 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs followed by IF staining and qRT-PCR and Western Blotting | NA | 0.84 | 0.7582 | 27602437 |
| PROM1 | 9454 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by IF staining and Western Blotting | NA | 0.84 | 0.7582 | 28430578 |
| PROM1 | 9454 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.84 | 0.7582 | 30843262 |
| PROM1 | 9454 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | qRT-PCR and Western Blotting | NA | 0.84 | 0.7582 | 32638620 |
| PROM1 | 9454 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs for CSC marker followed by Western Blotting | NA | 0.84 | 0.7582 | 29212193 |
| PROM1 | 9454 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by Western Blotting | NA | 0.84 | 0.7582 | 27644439 |
| PROM1 | 9454 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by Western Blotting | NA | 0.84 | 0.7582 | 28461325 |
| PROM1 | 9454 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by Western Blotting | NA | 0.84 | 0.7582 | 28970066 |
| PROM1 | 9454 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by IF staining | NA | 0.84 | 0.7582 | 29178392 |
| PROM1 | 9454 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR | NA | 0.84 | 0.7582 | 32633423 |
| PROM1 | 9454 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA and FACs | NA | 0.84 | 0.7582 | 34075691 |
| PROM1 | 9454 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA and FACs | NA | 0.84 | 0.7582 | 34646768 |
| PROM1 | 9454 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by FACs | NA | 0.84 | 0.7582 | 32572790 |
| PROM1 | 9454 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs followed by SFA | NA | 0.84 | 0.7582 | 31073886 |
| PROM1 | 9454 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs followed by SFA | NA | 0.84 | 0.7582 | 31438772 |
| PROM1 | 9454 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | MACs followed by SFA | NA | 0.84 | 0.7582 | 31048191 |
| PROM1 | 9454 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by FACs | NA | 0.84 | 0.7582 | 32863948 |
| ALDH1A1 | 402 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | ALDEFLUOR assay followed by qRT-PCR and Western Blotting | NA | 0.6 | 0.684 | 32638620 |
| ALDH1A1 | 402 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | Acetylcholine | SFA followed by qRT-PCR and IF staining | NA | 0.6 | 0.684 | 30207200 |
| ALDH1A1 | 402 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by ALDEFLUOR assay and IF staining | NA | 0.6 | 0.684 | 32707998 |
| ALDH1A1 | 402 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | ALDEFLUOR assay followed by SFA and qRT-PCR | NA | 0.6 | 0.684 | 34628473 |
| ALDH1A1 | 402 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR and FACs | NA | 0.6 | 0.684 | 27157616 |
| ALDH1A1 | 402 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA and Western Blotting | NA | 0.6 | 0.684 | 34646768 |
| ALDH1A1 | 402 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by Western Blotting | NA | 0.6 | 0.684 | 28337375 |
| ALDH1A1 | 402 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | ALDEFLUOR assay followed by SFA | NA | 0.6 | 0.684 | 27279633 |
| ALDH1A1 | 402 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | ALDEFLUOR assay followed by SFA | NA | 0.6 | 0.684 | 29212193 |
| ALDH1A1 | 402 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs followed by SFA | NA | 0.6 | 0.684 | 27620279 |
| ALDH1A1 | 402 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by ALDEFLUOR assay | NA | 0.6 | 0.684 | 34173116 |
| ALDH1A1 | 402 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by ALDEFLUOR assay | NA | 0.6 | 0.684 | 32863948 |
| ALDH1A1 | 402 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by FACs | NA | 0.6 | 0.684 | 31879364 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by IF staining and Western Blotting | NA | 0.52 | 1 | 28430578 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by Western Blotting and IF staining | NA | 0.52 | 1 | 33288885 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.52 | 1 | 30843262 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | Acetylcholine | SFA followed by qRT-PCR and IF staining | NA | 0.52 | 1 | 30207200 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs followed by Western Blotting and SFA | NA | 0.52 | 1 | 29212193 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs and SFA followed by Western Blotting | NA | 0.52 | 1 | 28186678 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by FACs and IF staining | NA | 0.52 | 1 | 32707998 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs followed by RT-PCR and SFA | NA | 0.52 | 1 | 30543303 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR and FACs | NA | 0.52 | 1 | 27157616 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs and qRT-PCR | NA | 0.52 | 1 | 32203224 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs followed by RT-PCR | NA | 0.52 | 1 | 25081334 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs followed by RT-PCR and SFA | NA | 0.52 | 1 | 28692437 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by Western Blotting | NA | 0.52 | 1 | 27644439 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by Western Blotting | NA | 0.52 | 1 | 28461325 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by Western Blotting | NA | 0.52 | 1 | 28970066 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | Western Blotting | NA | 0.52 | 1 | 27878307 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | IF staining | NA | 0.52 | 1 | 31489619 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by IF staining | NA | 0.52 | 1 | 29178392 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SP assay followed by SFA and IF staining | NA | 0.52 | 1 | 31345097 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA and IF staining | NA | 0.52 | 1 | 28383763 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs for SFA followed by qRT-PCR | NA | 0.52 | 1 | 27511210 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR | NA | 0.52 | 1 | 27735991 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR | NA | 0.52 | 1 | 29512256 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by RT-PCR | NA | 0.52 | 1 | 33725258 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | qRT-PCR | NA | 0.52 | 1 | 32099405 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR | NA | 0.52 | 1 | 28822889 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | Cisplatin | FACs | NA | 0.52 | 1 | 30250614 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs | NA | 0.52 | 1 | 30485589 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs followed by SFA | NA | 0.52 | 1 | 27620279 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs followed by SFA | NA | 0.52 | 1 | 31213895 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA and FACs | NA | 0.52 | 1 | 34075691 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA and FACs | NA | 0.52 | 1 | 34646768 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs followed by SFA | NA | 0.52 | 1 | 19415765 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs followed by SFA | NA | 0.52 | 1 | 31073886 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs followed by SFA | NA | 0.52 | 1 | 26155313 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | MACs followed by SFA | NA | 0.52 | 1 | 31048191 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by FACs | NA | 0.52 | 1 | 31879364 |
| CD44 | 1681 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by FACs | NA | 0.52 | 1 | 32863948 |
| EPCAM | 11529 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by IF staining and Western Blotting | NA | 0.52 | 0.211 | 28430578 |
| EPCAM | 11529 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.52 | 0.211 | 28959362 |
| EPCAM | 11529 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs followed by SFA | NA | 0.52 | 0.211 | 31073886 |
| KLF4 | 6348 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by Western Blotting and IF staining | NA | 0.52 | 0.0891 | 32160650 |
| KLF4 | 6348 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA and Western Blotting | NA | 0.52 | 0.0891 | 34278502 |
| KLF4 | 6348 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR | NA | 0.52 | 0.0891 | 27157616 |
| KLF4 | 6348 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR | NA | 0.52 | 0.0891 | 29512256 |
| KLF4 | 6348 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR | NA | 0.52 | 0.0891 | 32633423 |
| KLF4 | 6348 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by RT-PCR | NA | 0.52 | 0.0891 | 33725258 |
| KLF4 | 6348 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | Acetylcholine | SFA followed by qRT-PCR | NA | 0.52 | 0.0891 | 30207200 |
| KLF4 | 6348 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR | NA | 0.52 | 0.0891 | 28822889 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by IF staining and Western Blotting | NA | 0.52 | 0.5461 | 28430578 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs for CSC marker followed by qRT-PCR and Western Blotting | NA | 0.52 | 0.5461 | 27602437 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | qRT-PCR and Western Blotting followed by SFA | NA | 0.52 | 0.5461 | 31037832 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA and Western Blotting and qRT-PCR | NA | 0.52 | 0.5461 | 34173116 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.52 | 0.5461 | 28959362 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.52 | 0.5461 | 31345097 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | qRT-PCR and Western Blotting | NA | 0.52 | 0.5461 | 32638620 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs for CSC marker followed by Western Blotting | NA | 0.52 | 0.5461 | 27279633 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA and Western Blotting | NA | 0.52 | 0.5461 | 34646768 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by Western Blotting | NA | 0.52 | 0.5461 | 27644439 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by Western Blotting | NA | 0.52 | 0.5461 | 28461325 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by Western Blotting | NA | 0.52 | 0.5461 | 33288885 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | RT-PCR followed by SFA | NA | 0.52 | 0.5461 | 30543303 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR | NA | 0.52 | 0.5461 | 27511210 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR | NA | 0.52 | 0.5461 | 29512256 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR | NA | 0.52 | 0.5461 | 34628473 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by RT-PCR | NA | 0.52 | 0.5461 | 33725258 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | RT-PCR | NA | 0.52 | 0.5461 | 25081334 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | RT-PCR and SFA | NA | 0.52 | 0.5461 | 28692437 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR | NA | 0.52 | 0.5461 | 26862521 |
| NANOG | 20857 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR | NA | 0.52 | 0.5461 | 32863948 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by IF staining and Western Blotting | NA | 0.52 | 0.6448 | 28430578 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by Western Blotting and IF staining | NA | 0.52 | 0.6448 | 32160650 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs for CSC marker followed by qRT-PCR and Western Blotting | NA | 0.52 | 0.6448 | 27602437 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA and Western Blotting and qRT-PCR | NA | 0.52 | 0.6448 | 34173116 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.52 | 0.6448 | 30843262 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.52 | 0.6448 | 31345097 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs for CSC marker followed by Western Blotting | NA | 0.52 | 0.6448 | 27279633 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs for CSC marker followed by Western Blotting | NA | 0.52 | 0.6448 | 29212193 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA and Western Blotting | NA | 0.52 | 0.6448 | 34278502 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA and Western Blotting | NA | 0.52 | 0.6448 | 34646768 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA and Western Blotting | NA | 0.52 | 0.6448 | 34845198 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by Western Blotting | NA | 0.52 | 0.6448 | 27644439 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by Western Blotting | NA | 0.52 | 0.6448 | 28337375 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by Western Blotting | NA | 0.52 | 0.6448 | 28461325 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by Western Blotting | NA | 0.52 | 0.6448 | 33288885 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | Western Blotting | NA | 0.52 | 0.6448 | 27878307 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | RT-PCR followed by SFA | NA | 0.52 | 0.6448 | 30543303 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR | NA | 0.52 | 0.6448 | 27511210 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR | NA | 0.52 | 0.6448 | 27735991 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR | NA | 0.52 | 0.6448 | 29512256 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR | NA | 0.52 | 0.6448 | 32633423 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by RT-PCR | NA | 0.52 | 0.6448 | 33725258 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | qRT-PCR | NA | 0.52 | 0.6448 | 32203224 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | qRT-PCR | NA | 0.52 | 0.6448 | 32099405 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | RT-PCR | NA | 0.52 | 0.6448 | 25081334 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | Trastuzumab | RT-PCR | NA | 0.52 | 0.6448 | 25669984 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | RT-PCR and SFA | NA | 0.52 | 0.6448 | 28692437 |
| POU5F1 | 9221 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR | NA | 0.52 | 0.6448 | 32863948 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by IF staining and Western Blotting | NA | 0.52 | 0.5695 | 28430578 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by Western Blotting and IF staining | NA | 0.52 | 0.5695 | 33288885 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by Western Blotting and IF staining | NA | 0.52 | 0.5695 | 32160650 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs for CSC marker followed by qRT-PCR and Western Blotting | NA | 0.52 | 0.5695 | 27602437 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | qRT-PCR and Western Blotting followed by SFA | NA | 0.52 | 0.5695 | 31037832 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA and Western Blotting and qRT-PCR | NA | 0.52 | 0.5695 | 34173116 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.52 | 0.5695 | 28959362 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.52 | 0.5695 | 30843262 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.52 | 0.5695 | 31345097 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | qRT-PCR and Western Blotting | NA | 0.52 | 0.5695 | 32638620 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs for CSC marker followed by Western Blotting | NA | 0.52 | 0.5695 | 29212193 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA and Western Blotting | NA | 0.52 | 0.5695 | 34278502 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by Western Blotting | NA | 0.52 | 0.5695 | 27644439 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by Western Blotting | NA | 0.52 | 0.5695 | 28337375 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by Western Blotting | NA | 0.52 | 0.5695 | 28461325 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR | NA | 0.52 | 0.5695 | 27157616 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR | NA | 0.52 | 0.5695 | 27511210 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR | NA | 0.52 | 0.5695 | 29512256 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR | NA | 0.52 | 0.5695 | 32633423 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by RT-PCR | NA | 0.52 | 0.5695 | 33725258 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | RT-PCR | NA | 0.52 | 0.5695 | 25081334 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | Acetylcholine | SFA followed by qRT-PCR | NA | 0.52 | 0.5695 | 30207200 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR | NA | 0.52 | 0.5695 | 26862521 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR | NA | 0.52 | 0.5695 | 28822889 |
| SOX2 | 11195 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR | NA | 0.52 | 0.5695 | 32863948 |
| ALDH3A1 | 405 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs for CSC marker followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.0074 | 27279633 |
| HES1 | 5192 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.0095 | 28959362 |
| HMGA2 | 5009 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.0042 | 28337375 |
| HMGA2 | 5009 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | Western Blotting | NA | 0.48 | 0.0042 | 27878307 |
| MALAT1 | 29665 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | qRT-PCR and Western Blotting followed by SFA | NA | 0.48 | 0.0074 | 31037832 |
| NME2 | 7850 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.0042 | 34628473 |
| NOTCH1 | 7881 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR and Western Blotting | NA | 0.48 | 0.0477 | 28959362 |
| NOTCH1 | 7881 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA and Western Blotting | NA | 0.48 | 0.0477 | 34845198 |
| NOTCH1 | 7881 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by Western Blotting | NA | 0.48 | 0.0477 | 32863948 |
| NOTCH1 | 7881 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR | NA | 0.48 | 0.0477 | 32633423 |
| USP22 | 12621 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | RT-PCR followed by SFA and Western Blotting | NA | 0.48 | 0.0032 | 30543303 |
| RORA | 10258 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs for CSC marker followed by qRT-PCR and IF staining | NA | 0.44 | 0.0021 | 27602437 |
| STAT3 | 11364 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA and FACs followed by Western Blotting | NA | 0.4 | 0.0223 | 26862521 |
| HSPA8 | 5241 | HTM/LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs for CSC marker followed by Proteomics and Western Blotting | Up | 0.36 | 0.0085 | 25081334 |
| LGR5 | 4504 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs followed by SFA and IF staining | NA | 0.36 | 0.0753 | 28383763 |
| LGR5 | 4504 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by Western Blotting | NA | 0.36 | 0.0753 | 28970066 |
| LGR5 | 4504 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR | NA | 0.36 | 0.0753 | 34628473 |
| LGR5 | 4504 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR | NA | 0.36 | 0.0753 | 32863948 |
| LGR5 | 4504 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | Cisplatin | FACs | NA | 0.36 | 0.0753 | 30250614 |
| CD24 | 1645 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs and qRT-PCR | NA | 0.32 | 0.456 | 32203224 |
| BMI1 | 1066 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs for CSC marker followed by Western Blotting | NA | 0.28 | 0.1135 | 27279633 |
| BMI1 | 1066 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.1135 | 27644439 |
| BMI1 | 1066 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | RT-PCR followed by SFA | NA | 0.28 | 0.1135 | 30543303 |
| BMI1 | 1066 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | RT-PCR | NA | 0.28 | 0.1135 | 25081334 |
| CD24 | 1645 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.456 | 28461325 |
| CD24 | 1645 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs followed by SFA | NA | 0.28 | 0.456 | 27620279 |
| CD24 | 1645 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs followed by SFA | NA | 0.28 | 0.456 | 29212193 |
| CD24 | 1645 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs followed by SFA | NA | 0.28 | 0.456 | 19415765 |
| CTNNB1 | 2514 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0647 | 32863948 |
| GLI1 | 4317 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0308 | 32863948 |
| MSI1 | 7330 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0201 | 28461325 |
| MTDH | 29608 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | Western Blotting followed by CFA | NA | 0.28 | 0.0011 | 31632151 |
| MYC | 7553 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.1304 | 28337375 |
| MYC | 7553 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.1304 | 28461325 |
| MYC | 7553 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.1304 | 33288885 |
| MYC | 7553 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | Western Blotting | NA | 0.28 | 0.1304 | 28186678 |
| MYC | 7553 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | RT-PCR followed by SFA | NA | 0.28 | 0.1304 | 30543303 |
| MYC | 7553 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR | NA | 0.28 | 0.1304 | 34628473 |
| MYC | 7553 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | qRT-PCR | NA | 0.28 | 0.1304 | 32099405 |
| MYC | 7553 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | RT-PCR and SFA | NA | 0.28 | 0.1304 | 28692437 |
| MYC | 7553 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR | NA | 0.28 | 0.1304 | 26862521 |
| OTUB2 | 20351 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA and Western Blotting | NA | 0.28 | 0.0021 | 34646768 |
| RAC1 | 9801 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0032 | 28461325 |
| SLC34A2 | 11020 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0011 | 29178392 |
| SLC38A2 | 13448 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA and Western Blotting | NA | 0.28 | 0.0011 | 34173116 |
| SOX9 | 11204 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA and Western Blotting | NA | 0.28 | 0.0244 | 34845198 |
| TBL1XR1 | 29529 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.0011 | 33288885 |
| TWIST1 | 12428 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | Western Blotting | NA | 0.28 | 0.0191 | 27878307 |
| TWIST1 | 12428 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR | NA | 0.28 | 0.0191 | 26862521 |
| MIR132 | 31516 | HTM/LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by Transcriptomics and qPCR | Up | 0.24 | 0.0032 | 28383763 |
| ABCG2 | 74 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | RT-PCR | NA | 0.2 | 0.1739 | 25081334 |
| CDH2 | 1759 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0085 | 26862521 |
| CLSPN | 19715 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0032 | 30240769 |
| CSPG4 | 2466 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | RT-PCR and SFA | NA | 0.2 | 0.0032 | 28692437 |
| CSPG4 | 2466 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | RT-PCR followed by SFA | NA | 0.2 | 0.0011 | 30543303 |
| FEZF1-AS1 | 41001 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | qRT-PCR | NA | 0.2 | 0.0021 | 32638620 |
| JAG1 | 6188 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | Trastuzumab | RT-PCR | NA | 0.2 | 0.0117 | 25669984 |
| MET | 7029 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | qRT-PCR | NA | 0.2 | 0.0191 | 32099405 |
| MIR193A | 31563 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs for CSC marker followed by RT-PCR | NA | 0.2 | 0.0042 | 30485589 |
| MIR200C | 31580 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0074 | 32633423 |
| MIR25 | 31609 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs for CSC marker followed by qRT-PCR | NA | 0.2 | 0.0032 | 29178392 |
| MIR483 | 32340 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0053 | 27511210 |
| MIR520C | 32108 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0011 | 32633423 |
| NANOGP8 | 23106 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qPCR | NA | 0.2 | 0.0011 | 29689047 |
| NES | 7756 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | RT-PCR | NA | 0.2 | 0.0573 | 25081334 |
| SMO | 11119 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | RT-PCR followed by SFA | NA | 0.2 | 0.0212 | 30543303 |
| SMO | 11119 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | RT-PCR and SFA | NA | 0.2 | 0.0212 | 28692437 |
| SNAI1 | 11128 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.0212 | 26862521 |
| VIM | 12692 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.017 | 26862521 |
| GSTP1 | 4638 | HTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs followed by SFA | Up | 0.12 | 0.0053 | 31073886 |
| CXCR4 | 2561 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by FACs | NA | 0.12 | 0.0498 | 32863948 |
| FIT3 | NA | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs | NA | 0.12 | 0.0011 | 19415765 |
| FUT4 | 4015 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs | NA | 0.12 | 0.0085 | 19415765 |
| THY1 | 11801 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs followed by SFA | NA | 0.12 | 0.0371 | 31073886 |
| THY1 | 11801 | LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | SFA followed by FACs | NA | 0.12 | 0.0371 | 32863948 |
| ECHS1 | 3151 | HTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs for CSC marker followed by Proteomics | Down | 0.08 | 0.0042 | 25081334 |
| EIF3S2 | 3272 | HTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0011 | 25081334 |
| HLA-B | 4932 | HTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0021 | 25081334 |
| IFT74 | 21424 | HTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0011 | 25081334 |
| KRT1 | 6412 | HTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0042 | 25081334 |
| KRT19 | 6436 | HTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs for CSC marker followed by Proteomics | Down | 0.08 | 0.0074 | 25081334 |
| KRT8 | 6446 | HTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs for CSC marker followed by Proteomics | Down | 0.08 | 0.0074 | 25081334 |
| KRT9 | 6447 | HTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs for CSC marker followed by Proteomics | Down | 0.08 | 0.0042 | 25081334 |
| KRT9 | 6447 | HTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0042 | 25081334 |
| PGAM1 | 8888 | HTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0042 | 25081334 |
| TPI1 | 12009 | HTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0042 | 25081334 |
| TPM3 | 12012 | HTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0021 | 25081334 |
| TRAP1 | 16264 | HTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs for CSC marker followed by Proteomics | Down | 0.08 | 0.0053 | 25081334 |
| ENO1 | 3350 | HTM/LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0095 | 25081334 |
| EZR | 12691 | HTM/LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs for CSC marker followed by Proteomics | Up | 0.08 | 0.0064 | 25081334 |
| PHB | 8912 | HTM/LTM | Gastric Cancer | Adenocarcinoma | MKN45 | NA | FACs for CSC marker followed by Proteomics | Down | 0.08 | 0.0032 | 25081334 |